Welcome to our dedicated page for Eastman Kodak news (Ticker: KODK), a resource for investors and traders seeking the latest updates and insights on Eastman Kodak stock.
Eastman Kodak Company reports recurring developments across commercial print, advanced materials and chemicals, and brand-related businesses. Company updates commonly cover quarterly and annual results, earnings calls, segment revenue and Operational EBITDA trends, cash balances, term-loan repayments, and balance-sheet actions tied to pension-plan assets.
Kodak news also includes product and portfolio activity such as motion picture film stocks, regulated laboratory reagents including phosphate buffered saline and water for injection, specialty chemicals, and battery-electrode work through the RaiCore platform. These updates reflect the company’s mix of print technology, film materials, chemical manufacturing, and applied materials initiatives.
Kodak (NYSE: KODK) reported Q2 2026 consolidated revenue of $311 million, up 18% year over year, with segment revenues of $195 million in Print, $105 million in Advanced Materials & Chemicals (AM&C) and $7 million in Brand. Gross profit rose to $82 million, lifting margin to 26% from 19%.
GAAP net income was $17 million versus a $26 million loss in Q2 2025. Operational EBITDA increased to $36 million from $9 million, driven by improved pricing and higher volume, partially offset by higher silver and aluminum costs and higher SG&A. Cash ended at $290 million, down $47 million from December 31, 2025, mainly due to $101 million of term loan repayments, partly offset by $87 million of proceeds from KRIP investment redemptions. Long-term debt decreased to $108 million from $208 million.
Kodak (NYSE:KODK) plans to host its Second-Quarter 2026 earnings conference call on Tuesday, August 4, 2026, at 5:00 p.m. EDT. Executive Chairman and CEO James Continenza and CFO David Bullwinkle will discuss financial results with analysts and investors via a live webcast.
Participants can access the webcast at https://edge.media-server.com/mmc/p/jt6vqifp.
Kodak (NYSE:KODK) has licensed its brand to Hubble Connected for a new family technology ecosystem spanning baby, kids, and pet categories. The Kodak-licensed lineup includes smart nursery monitors, connected pet monitoring and feeding products, and kids' smartwatches and phones.
All devices will connect through the Kodak HubbleClub app, offering a unified platform for home, nursery, pet, and family communication. The collection debuts May 13–15, 2026 at the ABC Kids Expo in Las Vegas.
Eastman Kodak (NYSE: KODK) reported Q1 2026 results on May 7, 2026: consolidated revenue of $265 million (up 7% YoY), gross profit of $57 million (up 24% YoY) and Operational EBITDA of $15 million (up $13 million YoY). GAAP net loss was $16 million. Cash at quarter end was $299 million.
Print and Advanced Materials & Chemicals both posted revenue gains; foreign exchange added $7 million to revenue. Inventory increased, driven by silver and aluminum commodity costs.
Eastman Kodak (NYSE:KODK) will host its First-Quarter 2026 earnings conference call on May 7, 2026 at 5:00 PM EDT. Executive Chairman & CEO James Continenza and CFO David Bullwinkle will discuss Q1 results with analysts and investors. A live webcast is available at the provided participant link.
Investor and media contact information is published for follow-up.
Kodak (NYSE: KODK) announced KODAK VERITA 200D 5206/7206, a new color negative motion picture film available in 65mm, 35mm, and 16mm. VERITA 200D was developed with Sam Levinson and cinematographer Marcell Rév and was used to shoot more than one million feet for Euphoria Season 3, which premiered April 12, 2026.
The stock emphasizes detailed highlights, high color saturation, deep blacks, warm skin tones and a shorter but rich dynamic range versus VISION3. VERITA 200D is a specialty stock available by request through Kodak sales representatives.
Ateios Systems and Kodak (KODK) expanded the RaiCore™ electrode platform to LCO, LFP, and NMC cathodes and earned third-party PFAS-free verification. Independent testing found total organic fluorine below 20 ppm, well under the 100-ppm regulatory threshold. Ateios also launched 4th-generation RaiCore™ with >98% active material loading and pilot programs with leading OEMs.
NSF Energy Storage Engine grants and a non-FEOC supply chain supported validation and scale-up; samples and verification reports are available upon request.
Eastman Kodak Company (NYSE: KODK) reported Q4 and full‑year 2025 results showing revenue growth, improved gross profit and a stronger cash position. Consolidated Q4 revenue was $290M (+9% YoY) and FY revenue was $1.069B (+2% YoY).
Operational EBITDA rose to $22M in Q4 and $62M for FY 2025, while GAAP net loss was $108M in Q4 and $128M for the year. Year‑end cash was $337M, up $136M versus year‑end 2024.
Eastman Kodak (NYSE:KODK) will host its Fourth-Quarter and Full-Year 2025 earnings conference call on March 12, 2026 at 5:00pm EDT. Executive Chairman and CEO James Continenza and CFO David Bullwinkle will discuss financial results and answer investor questions.
A live webcast link is provided for public viewing and media and investor contacts are listed for follow-up.
Kodak (NYSE: KODK) expanded its pharmaceuticals portfolio on January 26, 2026, adding four regulated products: PBS 1X in low-endotoxin and RNase/DNase/Protease-free formulations and Water for Injection (WFI) in standard and RNase/DNase/Protease-free formulations. All four products are immediately available to U.S. research labs, biopharma developers, and CDMOs.
The products are manufactured in Kodak’s new cGMP-compliant pharmaceuticals facility in Rochester, NY, with lot-traceable quality, a multi-step water purification system, and sustainability features including energy-efficient lighting and water sterilization to reduce consumption and waste. Kodak said it is pursuing ISO 13485 certification and plans additional regulated pharmaceuticals in the future.